New procedure aims to cut repeat brain bleed surgeries

NCT ID NCT07626671

Not yet recruiting Disease control Sponsor: Charite University, Berlin, Germany Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a minimally invasive procedure called middle meningeal artery embolization (MMAE) for chronic subdural hematoma, a common brain bleed in older adults. The procedure blocks the blood supply to the hematoma membrane to prevent rebleeding. Researchers will follow 100 patients for 4 months to see if it reduces hematoma size, improves function, and lowers the need for repeat surgery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Middle meningeal artery embolization (minimally invasive procedure to block blood flow to the hematoma membrane)
What this could lead to: If successful, this could establish a standard follow-up and identify which patients benefit most from MMA embolization, reducing the need for repeat surgeries.
What could go wrong: This is a single-center registry with only 100 patients, so results may not apply broadly. The procedure itself carries small risks like bleeding or stroke, and it may not work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC SUBDURAL HEMATOMAS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Hematoma, Subdural, Chronic

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC SUBDURAL HEMATOMAS

More trials for these conditions

Other studies related to the condition(s) this trial covers.